PEN

#639
Penumbra, Inc.
344.4500
+1.22%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
342.9900
344.4600
Intervallo Annuale
221.2600
362.4100
Variazione giornaliera
+1.22%
Variazione Mensile
-4.16%
Variazione di 6 mesi
+32.48%
Variazione Annuale
+32.48%
Chiusura Precedente
340.2900
Open
343.0100
Bid
Ask
Low
342.9900
High
344.4600
Volume
1 188
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
  • Market Capitalization 13.4055 B
  • Employee 4 500
  • Founded 2004
  • CEO Adam Elsesser
  • Website www.penumbrainc.com
  • Headquarter Delaware, United States
  • FIGI BBG001BP92V1
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
68.79
Price to sales ratio
8.7
Dividends per share
—
Dividend yield %
—

Penumbra Inc

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend.

Notizie